Model-based screening for pancreatic cancer in Sweden.
Tomasz DrausDaniel AnsariRoland AnderssonPublished in: Scandinavian journal of gastroenterology (2022)
General screening for pancreatic cancer is not cost-effective, while screening of certain high-risk groups may be economically justified given the availability of a high-performing blood-based test.
Keyphrases